Development System
B2M_site_04 | SCGE Toolkit
Database of study and experiment data generated by the Somatic Cell Genome Editing Consortium
| A novel human T cell platform to define biological adverse effects of genome editing |
| B2M_site_04 |
| Calculated editing efficiency by targeted amplicon deep sequencing |
|
| Editing Efficiency |
| 15000000438 |
|
| SpCas9 |
| P3 Nucleofection Kit |
| Commercial Reagent |
| B2M_site_04 |
|
|
| Human |
| CD4/CD8 Human Primary T cell |
|
| Male |
|
| nucleofection |
|
| 75 pmol Cas9 protein; 3-fold molar excess of sgRNA |
|
|
|
|
| ribonucleoprotein (RNP) |
|
|
|
| Measured Values |
| Samples Size: | 3 |
| |
| Mean |
95.19  |
| 1 |
95.6380583337697  |
| 2 |
94.9095655416744  |
| 3 |
95.0261308343846  |
| |
|
| Publication Title |
|
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI |